Posted by Michael Wonder on 28 Apr 2022
Market for new medicines in Canada has not slowed over last two years, despite focus on COVID-19 treatments
28 April 2022 - An average of nine new medicines per quarter have been approved in Canada through the pandemic, with many more products moving through clinical trials.
Two new reports released by the Patented Medicine Prices Review Board detail the current status of the market for new medicines in Canada, finding an uptick in the number of new medicines approved and a brimming drug pipeline.
